• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HIN
Click for more information
0.00% $2.37

HEARTWARE INTERNATIONAL, INC - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HINHeartWare to Present at Wedbush Best Ideas Conference30/07/10
HINSecond Quarter Earnings Release Call28/07/10
HINAmended ASX Appendix 3Bs07/07/10
HINOption Exercise - ASX Appendix 3B02/07/10
HINOption Grant - ASX Appendix 3B02/07/10
HINAnnounces Board Succession25/06/10
HINHeartWare to present at Wells Fargo18/06/10
HINExercise of Options - ASX Appendix 3B18/06/10
HINHeartWare To Commence Destination Therapy TrialPRICE SENSITIVE15/06/10
HINExercise and Cancellation of Options07/06/10
HINChange of Director's Interest Notices07/05/10
HINHeartWare to present at Bank of America ML Conference07/05/10
HINAnnual General Meeting Results05/05/10
HINGrant of Incentive Equity - Appendix 3B05/05/10
HINAnnual General Meeting Materials05/05/10
HINFirst Quarter 2010 Financial StatementsPRICE SENSITIVE05/05/10
HINAppendix 3B05/05/10
HINFirst Quarter ResultsPRICE SENSITIVE04/05/10
HINExercise of Options - ASX Appendix 3B03/05/10
HINInitiates voluntary repairs and recalls certain controllersPRICE SENSITIVE27/04/10
HINFirst 100 Patient Commercial and Clinical DataPRICE SENSITIVE27/04/10
HINFirst Quarter Earnings Release Call13/04/10
HINAnnual Meeting of Stockholders13/04/10
HINFDA Approves Continued Access Protocol for BTTPRICE SENSITIVE08/04/10
HINAmended ASX Appendix 3B26/03/10
HINChange of Director's Interest Notice24/03/10
HINAppendix 3B - Exercise of Stock Options24/03/10
HINTo present at Barclays Capital 2010 Global Healthcare Conf.12/03/10
ACL +SandP Announces March SP/ASX Index Rebalance05/03/10
HINHeartWare to Present at Annual Roth Growth Conference05/03/10
HINGrant and Cancellation of Equity - ASX Appendix 3B03/03/10
HINChange of Director's Interest Notice03/03/10
HINAppendix 3B - Vesting of Preformance Rights03/03/10
HINAnnual Report for 2009 and ASX Appendix 4EPRICE SENSITIVE24/02/10
HINReports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2MPRICE SENSITIVE23/02/10
HINEnrollment of US Bridge to Transplant Trial Completed23/02/10
HINFourth Quarter and Annual Results for 2009 Earnings Call09/02/10
HINCapital Raising - Cleansing Notice03/02/10
HINCompletion of US$62 million Capital Raising03/02/10
HINCapital Raising - ASX Appendix 3B Allotment03/02/10
HINExercise and Cancellation of Options01/02/10
HINPricing of Public Offering of Common StockPRICE SENSITIVE28/01/10
HINProspectus for Public Offering of HeartWare Common StockPRICE SENSITIVE27/01/10
HINPublic Offering of HeartWare Common StockPRICE SENSITIVE27/01/10
HINShareholder Update12/01/10
HINHeartware to Present at J.P. Morgan Healthcare Conference07/01/10
HINThoratec Loan Facility Update04/01/10
HINExercise of Options - Appendix 3B10/12/09
HINChange of Director's Interest Notice08/12/09
HINChange of Director's Interest Notice02/12/09
HINHeartWare files IDE for Destination TherapyPRICE SENSITIVE24/11/09
HINChange of Director's Interest Notice23/11/09
HINExercise of (Expiring) Options23/11/09
HINChange of Director's Interest Notices17/11/09
HINExercise of Options - ASX Appendix 3B17/11/09
HINChange of Contact Details for HeartWare10/11/09
HINCEO Presenting at Investment Conferences09/11/09
HINRevenues of US$7.5M for Quarter Ended 30 September 2009PRICE SENSITIVE05/11/09
HINFinancial Statements for September 30, 200905/11/09
HINAdvance Notice of Q3 Earnings Call29/10/09
HINCapital Raising Allotment - ASX Appendix 3B27/10/09
HINStockholder Meeting Results - Capital Raising Approved27/10/09
HINCleansing Notice for Capital Raising27/10/09
HINFDA Approves Expansion to 40 Sites for US BTT TrialPRICE SENSITIVE06/10/09
HINExercise of Incentive Options05/10/09
HINNotice of Special Meeting of Stockholders - Capital Raising23/09/09
HINAnnual Employee Equity Allocation21/09/09
HINExercise and Cancellation of Options21/09/09
HINOption Exercise and Cancellations07/09/09
HINReinstatement to Official QuotationPRICE SENSITIVE02/09/09
HINHalf Yearly Report / Accounts and Review Report02/09/09
HINHeartWare Surpasses 50 US ImplantsPRICE SENSITIVE21/08/09
HINCleansing Notice for US$60 Miliion Placement18/08/09
HINCloses US$60 Million Placement18/08/09
HINASX Append. 4D And Half Year Financial Statements (US GAAP)PRICE SENSITIVE17/08/09
HINUS$55 Million Capital RaisingPRICE SENSITIVE11/08/09
HINJoint Termination of MergerPRICE SENSITIVE03/08/09
HINChange of Directors Interests - Annual Meeting Stock Issue31/07/09
HINIssue of Stock Pursuant to Annual Meeting Approval31/07/09
HINQuarterly Update And ASX Appendix 4CPRICE SENSITIVE31/07/09
HINAnnual Meeting Results30/07/09
HINUS FTC to Challenge Thoratec Acquisition of HeartWarePRICE SENSITIVE30/07/09
HINTrading HaltPRICE SENSITIVE30/07/09
HINAnnual Meeting Materials30/07/09
HINAnnual Meeting to be Webcast29/07/09
HINChange of Interests in Securities for Executive Director21/07/09
HINAppendix 3B - Vesting of RSUs06/07/09
HINAppendix 3B02/07/09
HINAppendix 3B18/06/09
HINRevised Thoratec Merger Documentation17/06/09
HINNotice of Annual General Meeting/Proxy Form12/06/09
HINCEO Presenting at JMP Securities Research Conference12/05/09
HINQuarterly Financial Statements 31 March 200912/05/09
HINThoratec Files Registration Statement08/05/09
HINQuarterly Update April 2009 and ASX Appendix 4CPRICE SENSITIVE30/04/09
HINEuropean Clinical Data UpdatePRICE SENSITIVE27/04/09
HINFirst International Sales and US Clinical Trial UpdatePRICE SENSITIVE31/03/09
HINAcquisition Update27/03/09
HINAppendix 3B18/03/09
ABB +SandP Announces March SP/ASX Index Rebalance06/03/09
HINHeartWare to Present at Wedbush Best Ideas Conference
30/07/10
HINSecond Quarter Earnings Release Call
28/07/10
HINAmended ASX Appendix 3Bs
07/07/10
HINOption Exercise - ASX Appendix 3B
02/07/10
HINOption Grant - ASX Appendix 3B
02/07/10
HINAnnounces Board Succession
25/06/10
HINHeartWare to present at Wells Fargo
18/06/10
HINExercise of Options - ASX Appendix 3B
18/06/10
HINHeartWare To Commence Destination Therapy Trial
15/06/10PRICE SENSITIVE
HINExercise and Cancellation of Options
07/06/10
HINChange of Director's Interest Notices
07/05/10
HINHeartWare to present at Bank of America ML Conference
07/05/10
HINAnnual General Meeting Results
05/05/10
HINGrant of Incentive Equity - Appendix 3B
05/05/10
HINAnnual General Meeting Materials
05/05/10
HINFirst Quarter 2010 Financial Statements
05/05/10PRICE SENSITIVE
HINAppendix 3B
05/05/10
HINFirst Quarter Results
04/05/10PRICE SENSITIVE
HINExercise of Options - ASX Appendix 3B
03/05/10
HINInitiates voluntary repairs and recalls certain controllers
27/04/10PRICE SENSITIVE
HINFirst 100 Patient Commercial and Clinical Data
27/04/10PRICE SENSITIVE
HINFirst Quarter Earnings Release Call
13/04/10
HINAnnual Meeting of Stockholders
13/04/10
HINFDA Approves Continued Access Protocol for BTT
08/04/10PRICE SENSITIVE
HINAmended ASX Appendix 3B
26/03/10
HINChange of Director's Interest Notice
24/03/10
HINAppendix 3B - Exercise of Stock Options
24/03/10
HINTo present at Barclays Capital 2010 Global Healthcare Conf.
12/03/10
ACL +SandP Announces March SP/ASX Index Rebalance
05/03/10
HINHeartWare to Present at Annual Roth Growth Conference
05/03/10
HINGrant and Cancellation of Equity - ASX Appendix 3B
03/03/10
HINChange of Director's Interest Notice
03/03/10
HINAppendix 3B - Vesting of Preformance Rights
03/03/10
HINAnnual Report for 2009 and ASX Appendix 4E
24/02/10PRICE SENSITIVE
HINReports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2M
23/02/10PRICE SENSITIVE
HINEnrollment of US Bridge to Transplant Trial Completed
23/02/10
HINFourth Quarter and Annual Results for 2009 Earnings Call
09/02/10
HINCapital Raising - Cleansing Notice
03/02/10
HINCompletion of US$62 million Capital Raising
03/02/10
HINCapital Raising - ASX Appendix 3B Allotment
03/02/10
HINExercise and Cancellation of Options
01/02/10
HINPricing of Public Offering of Common Stock
28/01/10PRICE SENSITIVE
HINProspectus for Public Offering of HeartWare Common Stock
27/01/10PRICE SENSITIVE
HINPublic Offering of HeartWare Common Stock
27/01/10PRICE SENSITIVE
HINShareholder Update
12/01/10
HINHeartware to Present at J.P. Morgan Healthcare Conference
07/01/10
HINThoratec Loan Facility Update
04/01/10
HINExercise of Options - Appendix 3B
10/12/09
HINChange of Director's Interest Notice
08/12/09
HINChange of Director's Interest Notice
02/12/09
HINHeartWare files IDE for Destination Therapy
24/11/09PRICE SENSITIVE
HINChange of Director's Interest Notice
23/11/09
HINExercise of (Expiring) Options
23/11/09
HINChange of Director's Interest Notices
17/11/09
HINExercise of Options - ASX Appendix 3B
17/11/09
HINChange of Contact Details for HeartWare
10/11/09
HINCEO Presenting at Investment Conferences
09/11/09
HINRevenues of US$7.5M for Quarter Ended 30 September 2009
05/11/09PRICE SENSITIVE
HINFinancial Statements for September 30, 2009
05/11/09
HINAdvance Notice of Q3 Earnings Call
29/10/09
HINCapital Raising Allotment - ASX Appendix 3B
27/10/09
HINStockholder Meeting Results - Capital Raising Approved
27/10/09
HINCleansing Notice for Capital Raising
27/10/09
HINFDA Approves Expansion to 40 Sites for US BTT Trial
06/10/09PRICE SENSITIVE
HINExercise of Incentive Options
05/10/09
HINNotice of Special Meeting of Stockholders - Capital Raising
23/09/09
HINAnnual Employee Equity Allocation
21/09/09
HINExercise and Cancellation of Options
21/09/09
HINOption Exercise and Cancellations
07/09/09
HINReinstatement to Official Quotation
02/09/09PRICE SENSITIVE
HINHalf Yearly Report / Accounts and Review Report
02/09/09
HINHeartWare Surpasses 50 US Implants
21/08/09PRICE SENSITIVE
HINCleansing Notice for US$60 Miliion Placement
18/08/09
HINCloses US$60 Million Placement
18/08/09
HINASX Append. 4D And Half Year Financial Statements (US GAAP)
17/08/09PRICE SENSITIVE
HINUS$55 Million Capital Raising
11/08/09PRICE SENSITIVE
HINJoint Termination of Merger
03/08/09PRICE SENSITIVE
HINChange of Directors Interests - Annual Meeting Stock Issue
31/07/09
HINIssue of Stock Pursuant to Annual Meeting Approval
31/07/09
HINQuarterly Update And ASX Appendix 4C
31/07/09PRICE SENSITIVE
HINAnnual Meeting Results
30/07/09
HINUS FTC to Challenge Thoratec Acquisition of HeartWare
30/07/09PRICE SENSITIVE
HINTrading Halt
30/07/09PRICE SENSITIVE
HINAnnual Meeting Materials
30/07/09
HINAnnual Meeting to be Webcast
29/07/09
HINChange of Interests in Securities for Executive Director
21/07/09
HINAppendix 3B - Vesting of RSUs
06/07/09
HINAppendix 3B
02/07/09
HINAppendix 3B
18/06/09
HINRevised Thoratec Merger Documentation
17/06/09
HINNotice of Annual General Meeting/Proxy Form
12/06/09
HINCEO Presenting at JMP Securities Research Conference
12/05/09
HINQuarterly Financial Statements 31 March 2009
12/05/09
HINThoratec Files Registration Statement
08/05/09
HINQuarterly Update April 2009 and ASX Appendix 4C
30/04/09PRICE SENSITIVE
HINEuropean Clinical Data Update
27/04/09PRICE SENSITIVE
HINFirst International Sales and US Clinical Trial Update
31/03/09PRICE SENSITIVE
HINAcquisition Update
27/03/09
HINAppendix 3B
18/03/09
ABB +SandP Announces March SP/ASX Index Rebalance
06/03/09
refresh Created with Sketch. REFRESH
 

Top Stories

Cyclone signs MOU with Vale for development of Iron Bear play

Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.